NASDAQ:OGI

OrganiGram - OGI Stock Forecast, Price & News

$1.13

+0.04 (+3.67%)

(As of 08/10/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.08
▼
$1.14
50-Day Range: $0.92
▼
$1.19
52-Week Range: $0.90
▼
$2.92

Volume: 1.40 million shs
Average Volume: 2.43 million shs
Market Capitalization: $354.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.05

OrganiGram MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 169.9% Upside
$3.05 Price Target
Short Interest: Healthy
3.21% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.94
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.09) to ($0.05) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Medical Sector

731st out of 1,108 stocks

Pharmaceutical Preparations Industry

369th out of 542 stocks

3.3

Analyst's Opinion

Consensus Rating
OrganiGram has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.05, OrganiGram has a forecasted upside of 169.9% from its current price of $1.13.
Amount of Analyst Coverage
OrganiGram has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.21% of the outstanding shares of OrganiGram have been sold short.
Short Interest Ratio / Days to Cover
OrganiGram has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in OrganiGram has recently increased by 0.40%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
OrganiGram does not currently pay a dividend.
Dividend Growth
OrganiGram does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OGI.

2.2

News and Social Media Coverage

News Sentiment
OrganiGram has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for OrganiGram this week, compared to 2 articles on an average week.
Search Interest
Only 12 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -14% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added OrganiGram to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OrganiGram insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 11.78% of the stock of OrganiGram is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for OrganiGram are expected to grow in the coming year, from ($0.09) to ($0.05) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of OrganiGram is -12.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of OrganiGram is -12.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
OrganiGram has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About OrganiGram (NASDAQ:OGI) Stock

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on OGI shares. Stifel Nicolaus dropped their price target on shares of OrganiGram from C$2.25 to C$1.50 in a research note on Friday, July 15th. Atb Cap Markets raised shares of OrganiGram from a "sector perform" rating to an "outperform" rating in a research note on Tuesday, April 12th. Finally, Alliance Global Partners reduced their price objective on shares of OrganiGram from C$2.25 to C$1.50 in a research note on Friday, July 15th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $3.04.

OrganiGram Stock Up 2.8 %

Shares of NASDAQ:OGI traded up $0.03 during trading on Wednesday, reaching $1.12. The stock had a trading volume of 67,981 shares, compared to its average volume of 4,437,495. OrganiGram has a 52 week low of $0.90 and a 52 week high of $2.92. The firm has a market capitalization of $351.35 million, a price-to-earnings ratio of -12.11 and a beta of 0.62. The stock has a fifty day simple moving average of $1.04 and a two-hundred day simple moving average of $1.32.

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

July 27, 2022 | streetinsider.com

Top Canadian Cannabis Stocks To Watch Before August - StreetInsider.com

July 24, 2022 | americanbankingnews.com

OrganiGram Holdings Inc. (NASDAQ:OGI) Forecasted to Earn FY2024 Earnings of ($0.01) Per Share

July 19, 2022 | americanbankingnews.com

OrganiGram (NASDAQ:OGI) PT Lowered to C$1.50 at Alliance Global Partners

July 17, 2022 | americanbankingnews.com

Raymond James Analysts Cut Earnings Estimates for OrganiGram Holdings Inc. (NASDAQ:OGI)

July 14, 2022 | fool.com

Here's What Moved Sundial Growers, Organigram, and Canopy Growth Stocks Today - The Motley Fool

July 14, 2022 | ca.investing.com

Organigram Holdings Reports Q2 Net Loss of $2.79M By Investing.com - Investing.com Canada

July 14, 2022 | seekingalpha.com

Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3 - Seeking Alpha

July 4, 2022 | fool.ca

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy! - The Motley Fool Canada

July 1, 2022 | ft.com

We should have limited empathy for the Big Boss resignation - Financial Times

June 24, 2022 | benzinga.com

Organigram Reaches Proposed Settlement In 2016 Class Action - Benzinga - Benzinga

June 7, 2022 | investing.com

As Cannabis Stocks Continue To Tank, Look At Sales Growth For Turnaround Sign - Investing.com

June 6, 2022 | finance.yahoo.com

Nextleaf Solutions (CSE: OILS) (OTCQB: OILFF) to Webcast Live June 7th at VirtualInvestorConferences.com - Yahoo Finance

May 13, 2022 | benzinga.com

Organigram Q2 Fiscal 2022 Revenue Grows 117% YoY Primaraly Because Of This - Benzinga - Benzinga

April 27, 2022 | benzinga.com

Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$3.7 - Benzinga

April 21, 2022 | nasdaq.com

Happy 420 Day! Buy This Top Pot Stock Now to Celebrate Later. - Nasdaq

April 20, 2022 | marketwatch.com

Leafly CEO rings Nasdaq bell on cannabis holiday - MarketWatch

April 20, 2022 | fool.com

3 Top Pot Stocks to Buy Right Now - The Motley Fool

April 14, 2022 | fool.com

Why OrganiGram Holdings Shares Rose 20.9% This Week - The Motley Fool

April 14, 2022 | nasdaq.com

3 Steps to Claiming the $4,194 Max Monthly Social Security Benefit - Nasdaq

April 14, 2022 | nasdaq.com

Why Shares in Delta Air Lines Continued Their Ascent Today - Nasdaq

April 14, 2022 | finance.yahoo.com

Why OrganiGram Holdings Shares Rose 20.9% This Week

April 12, 2022 | baystreet.ca

Demand for Cannabinol (CBN) Could Create a Massive Opportunity - Baystreet.ca

April 11, 2022 | nasdaq.com

Pre-Market Earnings Report for April 12, 2022 : ACI, KMX, OGI - Nasdaq

April 1, 2022 | seekingalpha.com

TLRY, CGC stocks higher as House clears Marijuana legalization bill (NASDAQ:TLRY) - Seeking Alpha

March 27, 2022 | benzinga.com

Here's Why OrganiGram Shares Are Rising

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Company Calendar

Last Earnings: 7/12/2021
Today: 8/11/2022
Fiscal Year End: 8/31/2022
Next Earnings (Estimated): 11/22/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:OGI
CUSIP: N/A
CIK: 1620737
Web: www.organigram.ca
Phone: (844) 644-4726
Fax: N/A
Employees: 841
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.05
High Stock Price Forecast: $5.30
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +169.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.09)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-103,090,000.00
Net Margins: -27.78%
Pretax Margin: -28.91%
Return on Equity: -11.81%
Return on Assets: -10.35%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.17
Quick Ratio: 3.06

Sales & Book Value

Annual Sales: $62.43 million
Price / Sales: 5.68
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.26 per share
Price / Book: 0.90

Miscellaneous

Outstanding Shares: 313,710,000
Free Float: N/A
Market Cap: $354.49 million
Optionable: Not Optionable
Beta: 0.62

Key Executives

Mr. Derrick W. West CPA (Age 55)
CPA, (CA), Chief Financial Officer
Comp: $244.82k
Ms. Helen Martin (Age 44)
Chief Legal Officer & Corp. Sec.
Comp: $229.3k
Mr. Gregory Engel (Age 57)
Special Advisor
Comp: $458.69k
Mr. Timothy Emberg
Chief Revenue Officer
Mr. Paolo De Luca C.A. (Age 49)
C.F.A, Chief Strategy Officer
Comp: $241.58k
Ms. Beena G. Goldenberg (Age 59)
CEO & Director
Ms. Nathalie Batten
VP of Operations
Amy Schwalm
VP of Investor Relations
Ms. Megan Amber McCrae
Sr. VP of Marketing & Communications
Tina Shannon
VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OGI Stock - Frequently Asked Questions

Should I buy or sell OrganiGram stock right now?: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings or view top-rated stocks.
What is OrganiGram's stock price forecast for 2022?: 6 equities research analysts have issued twelve-month price targets for OrganiGram's stock. Their OGI share price forecasts range from $1.50 to $5.30. On average, they expect the company's share price to reach $3.05 in the next twelve months. This suggests a possible upside of 169.9% from the stock's current price.
View analysts price targets for OGI or view top-rated stocks among Wall Street analysts.
How have OGI shares performed in 2022?: OrganiGram's stock was trading at $1.75 at the beginning of the year. Since then, OGI shares have decreased by 35.4% and is now trading at $1.13.
View the best growth stocks for 2022 here.
When is OrganiGram's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 22nd 2022.
View our OGI earnings forecast.
How were OrganiGram's earnings last quarter?: OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Monday, July, 12th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.02. The firm had revenue of $16.55 million for the quarter, compared to analysts' expectations of $13.95 million. OrganiGram had a negative net margin of 27.78% and a negative trailing twelve-month return on equity of 11.81%.
What other stocks do shareholders of OrganiGram own?: Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is OrganiGram's stock symbol?: OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
Who are OrganiGram's major shareholders?: OrganiGram's stock is owned by a variety of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (1.24%), Merlin Capital LLC (0.67%), Swiss National Bank (0.20%), Connor Clark & Lunn Investment Management Ltd. (0.18%), AdvisorShares Investments LLC (0.13%) and TD Asset Management Inc. (0.07%).
How do I buy shares of OrganiGram?: Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is OrganiGram's stock price today?: One share of OGI stock can currently be purchased for approximately $1.13.
How much money does OrganiGram make?: OrganiGram (NASDAQ:OGI) has a market capitalization of $354.49 million and generates $62.43 million in revenue each year. The company earns $-103,090,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis.
How many employees does OrganiGram have?: The company employs 841 workers across the globe.
How can I contact OrganiGram?: OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 8/11/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

OrganiGram - OGI Stock Forecast, Price & News

OrganiGram MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About OrganiGram (NASDAQ:OGI) Stock

Analyst Upgrades and Downgrades

OrganiGram Stock Up 2.8 %

OGI Stock News Headlines

OGI Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

OGI Stock - Frequently Asked Questions

Should I buy or sell OrganiGram stock right now?

What is OrganiGram's stock price forecast for 2022?

How have OGI shares performed in 2022?

When is OrganiGram's next earnings date?

How were OrganiGram's earnings last quarter?

What other stocks do shareholders of OrganiGram own?

What is OrganiGram's stock symbol?

Who are OrganiGram's major shareholders?

How do I buy shares of OrganiGram?

What is OrganiGram's stock price today?

How much money does OrganiGram make?

How many employees does OrganiGram have?

How can I contact OrganiGram?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™